SMAD7 Antikörper (AA 261-426)
Kurzübersicht für SMAD7 Antikörper (AA 261-426) (ABIN7622685)
Target
Alle SMAD7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 261-426
-
Verwendungszweck
- Mothers Against Decapentaplegic Homolog 7 (Smad7) Polyclonal Antibody
-
Sequenz
- Trp261~Arg426
-
Produktmerkmale
- The Mothers Against Decapentaplegic Homolog 7 (Smad7) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Affinity Chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- SMAD7 (SMAD, Mothers Against DPP Homolog 7 (SMAD7))
-
Andere Bezeichnung
- Smad7
-
Gen-ID
- 4092
-
UniProt
- O15105
-
Pathways
- Interferon-gamma Pathway, Cell-Cell Junction Organization
Target
-